Platelet Proteomics for Substance Use Disorder Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting substance use disorders, particularly chronic alcohol use, face challenges with high false negatives and false positives, and lack objective biochemical markers that can accurately monitor recent use and relapse, especially for hazardous or harmful alcohol consumption.
Innovation Solution
The development of platelet-associated substance use markers (PASU) using proteomic methods, specifically measuring proteins like monoamine oxidase-B (MAO-B) in platelet samples, which correlates with alcohol consumption levels and provides a ratio indicative of recent use or abstinence, employing affinity-type methods such as antibody-based or aptamer-based techniques, and multidimensional protein identification technology (MudPIT) for quantitation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If urine toxicology screens are used to detect substance use, then recent drug use can be identified, but the detection window is limited to hours or days and cannot detect chronic use patterns
Solution Approach 1:
Instead of detecting the substance itself or its direct metabolites in urine (conventional approach), the invention detects platelet proteins whose expression levels are altered by chronic substance use. This inverted approach shifts from detecting transient chemical presence to detecting persistent physiological changes in platelet proteomics, thereby extending the detection window from hours/days to weeks or months while maintaining accuracy for chronic use patterns
Solution Approach 2:
The invention utilizes platelets as they circulate through the body, carrying information about recent substance exposure. By measuring protein expression levels in these circulating platelets, the system performs preliminary detection of chronic use patterns before traditional urine screens would show positive results, enabling earlier intervention and monitoring of abstinence periods
2Loss of information
If traditional drug screening methods are used, then presence or absence of drugs can be determined, but no information about quantity or pattern of use is provided
Solution Approach 1:
The invention measures multiple platelet protein parameters (expression levels of specific proteins) that change in response to substance use. By monitoring the magnitude and pattern of these protein expression changes, the system infers both the quantity and temporal pattern of substance use, transforming a simple presence/absence detection into a quantitative assessment tool that provides comprehensive information about use history
Solution Approach 2:
The platelet protein profile serves multiple functions simultaneously: it detects substance exposure, quantifies the extent of use, determines patterns of consumption, and monitors abstinence periods. This multi-functional biomarker system replaces multiple separate testing approaches with a single comprehensive assay that provides holistic information about substance use behavior
3Reliability
If existing biochemical markers are used for alcohol use detection, then some indication of consumption can be obtained, but high false negatives and false positives occur and reliability is reduced
Solution Approach 1:
The invention segments the detection approach by focusing on specific platelet proteins (such as those involved in neurotransmitter metabolism or stress response) rather than relying on a single biochemical marker. This segmentation allows for a panel of proteins to be measured, where the combined pattern provides more reliable detection and reduces false results compared to individual markers
Solution Approach 2:
Platelets serve as an intermediary biomarker system that reflects central nervous system changes caused by substance use. Rather than directly measuring substances or their metabolites, the platelet protein expression levels act as mediators that translate neurological effects of chronic use into detectable peripheral blood markers, improving reliability by capturing the physiological impact rather than just chemical presence
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach offers sensitive and specific markers for detecting hazardous or harmful alcohol use, distinguishing between recent consumption and abstinence, and correlates with the quantity of alcohol consumed, aiding in diagnosis and monitoring of alcohol-related health issues.
Implementation Method 1
employing affinity-type methods such as antibody-based or aptamer-based techniques
Data Source
AI summary
The present invention relates to compositions and methods for identifying and quantifying platelet proteins that relate to various bodily states. The present invention further provides methods and compositions for determining whether an individual is using alcohol or other licit or illicit drugs at levels hazardous or harmful to their health. The invention also provides methods for identifying individuals who would benefit from or who may be harmed by specific medications or therapies.